Advocacy
Every discipline. Every patient. One mission. The AAWC is the largest multidisciplinary wound care organization in the United States — advancing education, shaping policy, and building the community that wound care professionals and their patients deserve.
Driving Better Outcomes in Wound Care
Join AAWC Now
The AAWC is an active member of the Alliance of Wound Care Stakeholders. The Alliance of Wound Care Stakeholders is a 501(c)(6) nonprofit multidisciplinary trade association representing physician specialty societies, clinical and patient associations, whose mission is to promote evidence-based quality care and access to products and services for people with chronic wounds.
Through advocacy and educational outreach in the regulatory, legislative, and public arenas, the Alliance unites leading wound care organizations and experts to advocate on public policy issues that may create barriers to patient access to treatments or care. Our key focus areas are coding, coverage and reimbursement; quality measures and wound care research.
FDA Public Meeting: Patient-Focused Drug Development for Nonhealing Chronic Wounds
August 25, 2026 | 10:00 AM – 4:30 PM ET | Hybrid
The U.S. Food and Drug Administration (FDA) is hosting a landmark public meeting dedicated to the patient experience with nonhealing chronic wounds — and the AAWC encourages every member to participate.
This hybrid event will bring together patients, caregivers, healthcare providers, medical product developers, and federal partners to share firsthand perspectives on how chronic wounds impact daily life, current treatment approaches, and what matters most when considering participation in clinical trials. The meeting will feature structured panel discussions across three focused sessions: the health effects and daily impacts of nonhealing wounds, current treatment approaches, and perspectives on clinical trial participation.
This is a rare and meaningful opportunity for the wound care community to speak directly to FDA leadership and help shape the future of drug development for the millions of patients living with chronic wounds.
How to Participate:
- Attend in person at the FDA White Oak Campus, Silver Spring, MD
- Join virtually via live webcast
- Apply to serve as a patient or care partner panelist by July 3, 2026
- Submit written comments to the public docket